Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis

Fig. 5

Sensitivity analysis on the prognostic value of mTOR/p-mTOR expression for (a) OS, (b) DFS and (c) CSS in patients with ESCC. CI, confidence interval; CSS, cancer-specific survival; DFS, disease-free survival; ESCC, esophageal squamous cell carcinoma; mTOR, mammalian target of rapamycin; p-mTOR, phosphorylated mammalian target of rapamycin; OS, overall survival

Back to article page